On September 21, an experiment will blast into orbit in an attempt to find a treatment for a very specific ailment: urinary tract infections (UTIs) in space.
By learning more about the way bacteria, and its response to antibiotics, is affected by microgravity, researchers hope to improve the health of astronauts on long-term missions.
UTIs are not just a problem for those on Earth; astronauts can get them too. Both on Earth and in space, the infections are commonly caused by the bacteria uropathogenic Escherichia coli, which is often treated by an antibiotic called gentamicin (Gm).
Read more on WIRED
Abigail Beall 